CXCR4 and prostate cancer: Previous studies in pancreatic and prostate cancer stem cells also showed that stimulation of CXCR4 signalling increased the cancer stem cell fraction, [24, 25] while inhibition reduced stem cell activity (measured by the ability to form metastases).